BioCentury
ARTICLE | Clinical News

Xpert Flu/RSV XC regulatory update

December 22, 2014 8:00 AM UTC

FDA approved the Xpert Flu/RSV XC from Cepheid to detect and differentiate influenza A, influenza Beta and respiratory syncytial virus (RSV) infection. The company launched the PCR-based kit that runs...